All Stories

  1. Once- vs. twice-daily inhaled therapy in asthma: a network meta-analysis

    Article • September 2019, European Respiratory Society (ERS)

    josuel ora

  2. Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease

    Article • Expert Opinion on Pharmacotherapy, February 2019, Taylor & Francis

    Mario Cazzola, josuel ora

  3. Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents

    Article • Expert Opinion on Pharmacotherapy, October 2018, Taylor & Francis

    josuel ora, Mario Cazzola

  4. The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis [Corrigendum]

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2018, Dove Medical Press

    josuel ora, Mario Cazzola

  5. The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2017, Dove Medical Press

    josuel ora, Mario Cazzola

  6. Airflow obstruction: is it asthma or is it COPD?

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2016, Dove Medical Press

    josuel ora, Mario Cazzola